Barry J. Maurer

<i>N</i>-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing

Hongtao Wang, Barry J. Maurer, Yu Liu et al. · Molecular Cancer Therapeutics · 2008 · 102 citations · Full text

Medicinal Chemistry, Drug Targeting, Chemoprevention Strategy +14

Fenretinide Cytotoxicity for Ewing’s Sarcoma and Primitive Neuroectodermal Tumor Cell Lines Is Decreased by Hypoxia and Synergistically Enhanced by Ceramide Modulators

Sandeep Batra, C. Patrick Reynolds, Barry J. Maurer · Cancer Research · 2004 · 88 citations

Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: A report from the new approaches to neuroblastoma therapy (NANT) consortium

Barry J. Maurer, Min H. Kang, Judith G. Villablanca et al. · Pediatric Blood & Cancer · 2013 · 86 citations · Full text

Novel submicroscopic extrachromosomal elements containing amplified genes in human cells

Barry J. Maurer, Eric Lai, Barbara A. Hamkalo et al. · Nature · 1987 · 84 citations

Chromatin, Cytogenetics, Human Cells +9

Improved Oral Delivery of<i>N</i>-(4-Hydroxyphenyl)Retinamide with a Novel LYM-X-SORB Organized Lipid Complex

Barry J. Maurer, Ondrej Kalous, David W. Yesair et al. · Clinical Cancer Research · 2007 · 60 citations